Variable | AT2S (n=20) | Adrenergic Vasopressors(n=60) | p-value |
---|---|---|---|
Age, years | 56.3 (10.8) | 53.1 (14.6) | 0.369 |
Female Sex, n (%) | 11 (55) | 9 (45) | 0.168 |
Race/ethnicity, n (%) | Â | Â | Â |
 -Black | 6 (30) | 10 (16.7) | 0.197 |
 -White | 7 (35) | 25 (41.7) | 0.598 |
 -Hispanic | 5 (25) | 22 (36.7) | 0.339 |
 Height, cm | 167.8 (9.6) | 169.1 (12.7) | 0.67 |
 Weight, kg | 95.1 (24.2) | 99.5 (29.3) | 0.544 |
 BMI, kg/m2 | 33.2 (6.8) | 34.9 (10.9) | 0.515 |
Dialysis preoperatively, n (%) | 20 (100) | 52 (86.7) | 0.191 |
 Time on dialysis, months | 86.7 (53.3) | 65.7 (36.1) | 0.036 |
Pertinent pre-transplant comorbidities, n (%) | Â | Â | Â |
 -Hypertension (%) | 18 (90) | 56 (93.3) | 0.624 |
 -Atrial Fibrillation (%) |  2(10) | 5 (8.3) | 0.672 |
 -Coronary Artery Disease (%) | 7(35) | 15 (25.4) | 0.215 |
 -Diabetes Type II (%) | 11(55) | 15 (25.4) | 0.518 |
Baseline Systolic BP, mmHg | 145.2 (23.6) | 157.3 (25.1) | 0.063 |
Baseline Diastolic BP, mmHg | 77.4 (13.4) | 85.9 (17.3) | 0.05 |
Baseline MAP, mmHg | 98.7 (16) | 108.1 (17.8) | 0.044 |
Baseline heart rate, bpm | 83 (17) | 71.5 (9.9) | <0.001 |